Monitoring changes in quality of life in patients with lung cancer by using specialised questionnaires: Implications for clinical practice

Supportive Care in Cancer

Volumn 22, Issue 8, 2014, Pages 2177-2183

  Lithoxopoulou, Hellie ^a   Zarogoulidis, Konstantinos ^a   Bostantzopoulou, Sevasti ^b   Eleftheriadou, Ellada ^a   Zarogoulidis, Paul ^a,c   Huang, Haidong ^d   Porpodis, Konstantinos ^a   Kioumis, Ioannis ^a   Tsiouda, Theodora ^e   Yarmus, Lonny ^f   Kontakiotis, Theodore ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b G Papanikolaou Hospital   (Greece)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e Internal Medicine Department Theigeneio Anticancer Hospital   (Greece)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FACT L; HADS; NSCLC; SCLC; SF 36

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; EMOTIONALITY; FUNCTIONAL ASSESSMENT OF CANCER THERAPY; GREECE; HEALTH SURVEY; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MENTAL HEALTH; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT REFERRAL; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION; SURVIVAL TIME; WELLBEING;

ANXIETY; DEPRESSION; HUMANS; LUNG NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SURVIVAL ANALYSIS;

EID: 84905094937     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2205-4     Document Type: Article

References (30)

1. Buccheri G, Ferrigno D (1994) Prognostic factors in lung cancer: tables and comments. Eur Respir J 7(7):1350-1364 (Pubitemid 24235056)
2. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP (2009) Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ 338:a3006. doi:10.1136/bmj.a3006
3. Kosmidis P (1996) Quality of life as a new end point. Chest 109(5 Suppl):110S-112S
4. Krech RL, Walsh D (1991) Symptoms of pancreatic cancer. J Pain Symptom Manag 6(6):360-367
5. Curtis EB, Krech R, Walsh TD (1991) Common symptoms in patients with advanced cancer. J Palliat Care 7(2):25-29
6. Goodare H, Smith R (1995) The rights of patients in research. BMJ 310(6990):1277-1278
7. Montazeri A (2009) Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 7:102. doi:10.1186/1477-7525-7-102
8. Montazeri A, Tavoli A, Mohagheghi MA, Roshan R, Tavoli Z (2009) Disclosure of cancer diagnosis and quality of life in cancer patients: should it be the same everywhere? BMC Cancer 9:39. doi:10.1186/1471-2407-9-39
9. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P (1995) Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12(3):199-220
10. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R (2002) Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324(7351):1417
11. Turner-Bowker DM, Bartley PJ, Ware JE Jr (eds) (2002) SF-36 Health Survey & "SF". Third-Edition (1988-2002) edn. Quality Metric Incorporated, Lincoln
12. Ware JE Jr, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M (1998) The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51(11):1159-1165 (Pubitemid 28527171)
13. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M (1989) The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 262(7):925-930 (Pubitemid 19208950)
14. McCallum J (1995) The SF-36 in an Australian sample: validating a new, generic health status measure. Aust J Public Health 19(2):160-166
15. SF-36 org: TOOLS. http://www.sf-36.org/tools/sf36.shtml. Accessed 03 Sept 2013
16. Anagnostopoulos F, Niakas D, Pappa E (2005) Construct validation of the Greek SF-36 Health Survey. Qual Life Res 14(8):1959-1965. doi:10.1007/s11136- 005-3866-8 (Pubitemid 41279619)
17. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67(6):361-370 (Pubitemid 13098606)
18. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52(2):69-77 (Pubitemid 34192886)
19. Mystakidou K, Tsilika E, Parpa E, Katsouda E, Galanos A, Vlahos L (2004) The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability. Support Care Cancer 12(12):821-825. doi:10.1007/s00520-004-0698-y (Pubitemid 40104775)
20. Michopoulos I, Douzenis A, Kalkavoura C, Christodoulou C, Michalopoulou P, Kalemi G, Fineti K, Patapis P, Protopapas K, Lykouras L (2008) Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample. Ann Gen Psychiatry 7:4. doi:10.1186/1744-859X-7-4
21. Salati M, Brunelli A, Xiume F, Refai M, Sabbatini A (2009) Quality of life in the elderly after major lung resection for lung cancer. Interact Cardiovasc Thorac Surg 8(1):79-83. doi:10.1510/icvts.2008.184986
22. Gralla RJ, Edelman MJ, Detterbeck FC, Jahan TM, Loesch DM, Limentani SA, Govindan R, Peng G, Monberg MJ, Obasaju CK, Socinski MA (2009) Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 17(3):307-313. doi:10.1007/s00520-008- 0489-y
23. Jain S, Poon I, Soliman H, Keller B, Kim A, Lochray F, Yeung L, Cheung P (2013) Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life. Radiother Oncol. doi:10.1016/j.radonc.2013.06.045
24. Dales RE, Belanger R, Shamji FM, Leech J, Crepeau A, Sachs HJ (1994) Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol 47(12):1443-1449
25. Dy SM, Asch SM, Lorenz KA, Weeks K, Sharma RK, Wolff AC, Malin JL (2011) Quality of end-of-life care for patients with advanced cancer in an academic medical center. J Palliat Med 14(4):451-457. doi:10.1089/jpm.2010.0434
26. Minet P, Bartsch P, Chevalier P, Raets D, Gras A, Dejardin-Closon MT, Lennes G (1987) Quality of life of inoperable non-small cell lung carcinoma. A randomized phase II clinical study comparing radiotherapy alone and combined radio-chemotherapy. Radiother Oncol 8(3):217-230 (Pubitemid 17112900)
27. Bradley JJ (1963) Severe localized pain associated with the depressive syndrome. Br J Psychiatry 109:741-745
28. Telfer MR, Shepherd JP (1993) Psychological distress in patients attending an oncology clinic after definitive treatment for maxillofacial malignant neoplasia. Int J Oral Maxillofac Surg 22(6):347-349
29. Turner S, Maher EJ, Young T, Young J, Vaughan Hudson G (1996) What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease. Br J Cancer 73(2):222-227 (Pubitemid 26028338)
30. Fallowfield L (1993) Quality of life in breast cancer - results from 3 cancer research campaign studies. Acta Clin Belg Suppl 15:19-23